1-800-887-8100
COPAXONE® (glatiramer acetate injection) 40 mg/mL Logo
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
MENU
Shared Solutions®
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
Copaxone® is the #1 prescribed brand for relapsing MS in the US 1*

In-home initial injection trainings help support patients’ injection experience

Because it's so important that patients get off to the right start with COPAXONE®, Teva’s Shared Solutions® provides free in-home initial injection training, so you can be confident that they are in supportive hands and encouraged to be compliant from the beginning.

Injection training sessions cover

COPAXONE® Injection Training

Refresher injection trainings help patients stay on track

Teva’s Shared Solutions® cares about your patients' COPAXONE® therapy experience and provides ongoing, in-home refresher injection training from Teva-trained nurses whenever they need it, at any stage of therapy. You can be confident that they are getting the continued face-to-face support that will help them stay compliant throughout their therapy experience.

View downloadable injection training and tracking tools available for your patients

A small change can make a big difference

Wherever needed throughout therapy
11MONTHS
75DAYS
Follow-ups and check-ins help track patients' progress
11-month check-ins confirm that injections are now part of a routine; provide motivation, encouragement, and guidance on improvement; and combat injection fatigue
75-day check-ins to reinforce initial training and assess how patients are adjusting to their new lifestyle routine
  • Your CNE can identify patients for Shared Solutions® PLUS
    • Personalized care plans for patients potentially at risk of discontinuing therapy

Have your patients contact Teva’s Shared Solutions® to schedule an initial or refresher injection training today

CONTACT Teva’s
SHARED SOLUTIONS®
DIRECTLY
Call
1-800-887-8100And Press 1 for Copaxone®


Teva’s Shared Solutions® is committed to helping your patients find financial solutions to start and stay on their COPAXONE® treatment
Explore financial solutions
The COPAXONE iTracker® 2.0 mobile app helps your patients manage their injections
FIND OUT MORE
Teva’s Clinical Nurse Educators (CNEs) offer personalized services and support for you, your patients, and the RMS community
View CNE services

Reference

  1. Jones JL, Scheidt DJ, Kaushal RS, Carroll CA. J Med Econ. 2013;16(2):213-220.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

IMPORTANT SAFETY INFORMATION

COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of

You are now leaving this website

The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.

While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.

Continue to site
×